Stelis Biopharma, RDIF collaborate to supply 200 million Sputnik V doses Ruchika Sharma20 March 2021 1:21 PM ISTSputnik V is a two-dose vaccine which uses two different human adenoviral vectors in the course of vaccination.
Strides Pharma raises Rs 1,415 crore in series B, C funding Ruchika Sharma19 March 2021 12:59 PM ISTNew Delhi: Strides Pharma Science on Friday said its biotech arm Stelis Biopharma concluded its series B and Series C fund raise for a cumulative...
Strides Pharma to demerge biotech business under Stelis Biopharma Ruchika Sharma5 Feb 2021 11:52 AM ISTStrides will demerge and list its biotech business under Stelis on a standalone basis enabling significant value unlocking for Strides Shareholders.
Aditya Puri appointed as Director of Stelis Biopharma, Advisor to Strides Group Ruchika Sharma8 Jan 2021 11:55 AM ISTBengaluru: Strides Pharma Science Limited announced that eminent corporate doyen Aditya Puri joins the Strides Group as an Advisor and also will be a...
